317 related articles for article (PubMed ID: 22088371)
61. MiR-650 inhibits the progression of glioma by targeting FAM83F.
Xu L; Yu QW; Fang SQ; Zheng YK; Qi JC
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8391-8398. PubMed ID: 30556880
[TBL] [Abstract][Full Text] [Related]
62. Impact of proliferation index on outcome in childhood malignant gliomas: results in a multi-institutional cohort.
Pollack IF; Hamilton RL; Burnham J; Holmes EJ; Finkelstein SD; Sposto R; Yates AJ; Boyett JM; Finlay JL
Neurosurgery; 2002 Jun; 50(6):1238-44; discussion 1244-5. PubMed ID: 12015841
[TBL] [Abstract][Full Text] [Related]
63. Prognostic significance of the immunohistochemical index of survivin in glioma: a comparative study with the MIB-1 index.
Uematsu M; Ohsawa I; Aokage T; Nishimaki K; Matsumoto K; Takahashi H; Asoh S; Teramoto A; Ohta S
J Neurooncol; 2005 May; 72(3):231-8. PubMed ID: 15937645
[TBL] [Abstract][Full Text] [Related]
64. Expression of interleukin-1beta mRNA and protein in human gliomas assessed by RT-PCR and immunohistochemistry.
Sasaki A; Tamura M; Hasegawa M; Ishiuchi S; Hirato J; Nakazato Y
J Neuropathol Exp Neurol; 1998 Jul; 57(7):653-63. PubMed ID: 9690669
[TBL] [Abstract][Full Text] [Related]
65. Application of Neurite Orientation Dispersion and Density Imaging in Assessing Glioma Grades and Cellular Proliferation.
Li SH; Jiang RF; Zhang J; Su CL; Chen XW; Zhang JX; Jiang JJ; Zhu WZ
World Neurosurg; 2019 Nov; 131():e247-e254. PubMed ID: 31349073
[TBL] [Abstract][Full Text] [Related]
66. EZH2 expression in gliomas: Correlation with CDKN2A gene deletion/ p16 loss and MIB-1 proliferation index.
Purkait S; Sharma V; Jha P; Sharma MC; Suri V; Suri A; Sharma BS; Sarkar C
Neuropathology; 2015 Oct; 35(5):421-31. PubMed ID: 26096306
[TBL] [Abstract][Full Text] [Related]
67. [MicroRNA383 regulates expression of PRDX3 in human medulloblastomas].
Wang XM; Zhang SF; Cheng ZQ; Peng QZ; Hu JT; Gao LK; Xu J; Jin HT; Liu HY
Zhonghua Bing Li Xue Za Zhi; 2012 Aug; 41(8):547-52. PubMed ID: 23157748
[TBL] [Abstract][Full Text] [Related]
68. iASPP, a microRNA‑124 target, is aberrantly expressed in astrocytoma and regulates malignant glioma cell migration and viability.
Liu X; Kang J; Sun S; Luo Y; Ji X; Zeng X; Zhao S
Mol Med Rep; 2018 Jan; 17(1):1970-1978. PubMed ID: 29257240
[TBL] [Abstract][Full Text] [Related]
69. Correlation between deregulated expression of PER2 gene and degree of glioma malignancy.
Wang F; Luo Y; Li C; Chen L
Tumori; 2014; 100(6):e266-72. PubMed ID: 25688509
[TBL] [Abstract][Full Text] [Related]
70. Relationship between Ki-67 labeling index and survival in high-grade glioma patients treated after surgery with tamoxifen.
Mastronardi L; Guiducci A; Puzzilli F; Ruggeri A
J Neurosurg Sci; 1999 Dec; 43(4):263-70. PubMed ID: 10864388
[TBL] [Abstract][Full Text] [Related]
71. Decreased MiR-17 in glioma cells increased cell viability and migration by increasing the expression of Cyclin D1, p-Akt and Akt.
Sun G; SiMa G; Wu C; Fan Y; Tan Y; Wang Z; Cheng G; Li J
PLoS One; 2018; 13(1):e0190515. PubMed ID: 29351283
[TBL] [Abstract][Full Text] [Related]
72. Clinicopathological features, MIB-1 labeling index and apoptotic index in recurrent astrocytic tumors.
Ralte AM; Sharma MC; Karak AK; Mehta VS; Sarkar C
Pathol Oncol Res; 2001; 7(4):267-78. PubMed ID: 11882906
[TBL] [Abstract][Full Text] [Related]
73. Application of flow cytometry for evaluating clinical prognosis and histopathological grade of human glioma.
Lin YW; Tai SH; Chang CC; Chao LC; Wen MJ; Huang YH; Hung HY; Lee EJ
Neurol Res; 2016 Jul; 38(7):625-33. PubMed ID: 27264544
[TBL] [Abstract][Full Text] [Related]
74. Immunohistochemical expression of peripheral benzodiazepine receptors in human astrocytomas and its correlation with grade of malignancy, proliferation, apoptosis and survival.
Vlodavsky E; Soustiel JF
J Neurooncol; 2007 Jan; 81(1):1-7. PubMed ID: 16868661
[TBL] [Abstract][Full Text] [Related]
75. Dysregulation of microRNA-128 expression in WHO grades 2 glioma is associated with glioma-associated epilepsy: Down-regulation of miR-128 induces glioma-associated seizure.
Yuan Y; Xiang W; Yanhui L; Ruofei L; Yunhe M; Jiewen L; Qing M
Epilepsy Res; 2016 Nov; 127():6-11. PubMed ID: 27526390
[TBL] [Abstract][Full Text] [Related]
76. MicroRNA-132 targets PEA-15 and suppresses the progression of astrocytoma in vitro.
Geng F; Wu JL; Lu GF; Liang ZP; Duan ZL; Gu X
J Neurooncol; 2016 Sep; 129(2):211-20. PubMed ID: 27294355
[TBL] [Abstract][Full Text] [Related]
77. Apoptosis and survival in high-grade astrocytomas as related to tumor Fas (APO-1/CD95) expression.
Frankel B; Longo SL; Leach C; Canute GW; Ryken TC
J Neurooncol; 2002 Aug; 59(1):27-34. PubMed ID: 12222835
[TBL] [Abstract][Full Text] [Related]
78. Decreased miRNA-146a in glioblastoma multiforme and regulation of cell proliferation and apoptosis by target Notch1.
Hu HQ; Sun LG; Guo WJ
Int J Biol Markers; 2016 Jul; 31(3):e270-5. PubMed ID: 26916895
[TBL] [Abstract][Full Text] [Related]
79. Therapeutic implications of interferon regulatory factor (IRF)-1 and IRF-2 in diffusely infiltrating astrocytomas (DIA): response to interferon (IFN)-beta in glioblastoma cells and prognostic value for DIA.
Yoshino A; Katayama Y; Yokoyama T; Watanabe T; Ogino A; Ota T; Komine C; Fukushima T; Kusama K
J Neurooncol; 2005 Sep; 74(3):249-60. PubMed ID: 16187022
[TBL] [Abstract][Full Text] [Related]
80. MiR-448 downregulates CTTN to inhibit cell proliferation and promote apoptosis in glioma.
Su HY; Lin ZY; Peng WC; Guan F; Zhu GT; Mao BB; Dai B; Huang H; Hu ZQ
Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3847-3854. PubMed ID: 29949161
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
